Pl. Davis et Ks. Mccarty, SENSITIVITY OF ENHANCED MRI FOR THE DETECTION OF BREAST-CANCER - NEW,MULTICENTRIC, RESIDUAL, AND RECURRENT, European radiology, 7, 1997, pp. 289-298
Magnetic resonance imaging (MRI) of the breast brings the advantages o
f high resolution cross-sectional imaging to breast cancer diagnosis,
treatment and research: improved cancer detection, staging, selection
of therapy, evaluation of therapeutic response in vivo, detection of r
ecurrence, and even the development of new therapies. Until now breast
cancer treatment and research has been impeded by the limited means o
f evaluating the breast cancer in vivo: primarily clinical palpation a
nd mammography of the breast tumor. A review of the initial studies sh
ows that with the use of paramagnetic contrast agents, MRI has a sensi
tivity of 96 % for detecting breast cancers. MRT detects multicentric
disease with a sensitivity of 98 %, superior to any other modality. Th
e ability of MRI to detect recurrent local: breast cancer in the conse
rvatively treated breast is nearly 100 %. MRI is capable of monitoring
tumor response to chemotherapy and actually guiding therapeutic inter
ventions such as interstitial laser photocoagulation.